Analysis of the role of central and peripheral α2-adrenoceptor subtypes in gastric mucosal defense in the rat

K. Gyires, Z. Zádori, Nashwan Shujaa, Renáta Minorics, G. Falkay, P. Mátyus

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The present study confirmed our previous assumption on the crucial role of central α2B-like adrenoceptor subtype in gastric mucosal defense. It was found that beside clonidine, rilmenidine, an α2/imidazoline receptor agonist and ST-91, an α2B-adrenoceptor preferring agonist inhibited the mucosal lesions induced by ethanol given intracerebroventricularly (i.c.v.). The ED50 values for clonidine, rilmenidine and ST-91 are 0.2, 0.01 and 16 nmol/rat i.c.v., respectively. The effect was reversed by the intracerebroventricularly injected α2B/2C-adrenoceptor antagonists prazosin and ARC-239, indicating the potential involvement of central α2B/2C-adrenoceptor subtype in the protective action. The gastroprotective effect of adrenoceptor stimulants was reversed by bilateral cervical vagotomy, suggesting that vagal nerve is likely to convey the central action to the periphery. In gastric mucosa both nitric oxide and prostaglandins may mediate the centrally-induced effect, since both indomethacin and NG-nitro-l-arginine reversed the protective effect of α2-adrenergic stimulants. Though expression of mRNA of α2B-, as well as α2A- and α2C-adrenoceptor subtypes was demonstrated in gastric mucosa of the rat, the hydrophilic ST-91, given peripherally (orally, subcutaneously), failed to exert mucosal protection, in contrast with clonidine and rilmenidine which were also effective. Consequently, while peripheral α2B-adrenoceptors are not likely to be involved in gastric mucosal protection, activation of central α2B-like adrenoceptor subtype may initiate a chain of events, which result in a vagal dependent gastroprotective action.

Original languageEnglish
Pages (from-to)289-296
Number of pages8
JournalNeurochemistry International
Volume51
Issue number5
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Adrenergic Receptors
Stomach
rilmenidine
Clonidine
Gastric Mucosa
Prazosin
Vagotomy
Indomethacin
Adrenergic Agents
Prostaglandins
Arginine
Nitric Oxide
Ethanol
Messenger RNA
ST 91

Keywords

  • Clonidine
  • Expression of α-adrenoceptor subtypes
  • Gastric mucosal damage
  • Rat
  • Rilmenidine
  • ST-91

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Analysis of the role of central and peripheral α2-adrenoceptor subtypes in gastric mucosal defense in the rat. / Gyires, K.; Zádori, Z.; Shujaa, Nashwan; Minorics, Renáta; Falkay, G.; Mátyus, P.

In: Neurochemistry International, Vol. 51, No. 5, 10.2007, p. 289-296.

Research output: Contribution to journalArticle

@article{d94b8700da054f1288e409d9561b715c,
title = "Analysis of the role of central and peripheral α2-adrenoceptor subtypes in gastric mucosal defense in the rat",
abstract = "The present study confirmed our previous assumption on the crucial role of central α2B-like adrenoceptor subtype in gastric mucosal defense. It was found that beside clonidine, rilmenidine, an α2/imidazoline receptor agonist and ST-91, an α2B-adrenoceptor preferring agonist inhibited the mucosal lesions induced by ethanol given intracerebroventricularly (i.c.v.). The ED50 values for clonidine, rilmenidine and ST-91 are 0.2, 0.01 and 16 nmol/rat i.c.v., respectively. The effect was reversed by the intracerebroventricularly injected α2B/2C-adrenoceptor antagonists prazosin and ARC-239, indicating the potential involvement of central α2B/2C-adrenoceptor subtype in the protective action. The gastroprotective effect of adrenoceptor stimulants was reversed by bilateral cervical vagotomy, suggesting that vagal nerve is likely to convey the central action to the periphery. In gastric mucosa both nitric oxide and prostaglandins may mediate the centrally-induced effect, since both indomethacin and NG-nitro-l-arginine reversed the protective effect of α2-adrenergic stimulants. Though expression of mRNA of α2B-, as well as α2A- and α2C-adrenoceptor subtypes was demonstrated in gastric mucosa of the rat, the hydrophilic ST-91, given peripherally (orally, subcutaneously), failed to exert mucosal protection, in contrast with clonidine and rilmenidine which were also effective. Consequently, while peripheral α2B-adrenoceptors are not likely to be involved in gastric mucosal protection, activation of central α2B-like adrenoceptor subtype may initiate a chain of events, which result in a vagal dependent gastroprotective action.",
keywords = "Clonidine, Expression of α-adrenoceptor subtypes, Gastric mucosal damage, Rat, Rilmenidine, ST-91",
author = "K. Gyires and Z. Z{\'a}dori and Nashwan Shujaa and Ren{\'a}ta Minorics and G. Falkay and P. M{\'a}tyus",
year = "2007",
month = "10",
doi = "10.1016/j.neuint.2007.07.001",
language = "English",
volume = "51",
pages = "289--296",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Analysis of the role of central and peripheral α2-adrenoceptor subtypes in gastric mucosal defense in the rat

AU - Gyires, K.

AU - Zádori, Z.

AU - Shujaa, Nashwan

AU - Minorics, Renáta

AU - Falkay, G.

AU - Mátyus, P.

PY - 2007/10

Y1 - 2007/10

N2 - The present study confirmed our previous assumption on the crucial role of central α2B-like adrenoceptor subtype in gastric mucosal defense. It was found that beside clonidine, rilmenidine, an α2/imidazoline receptor agonist and ST-91, an α2B-adrenoceptor preferring agonist inhibited the mucosal lesions induced by ethanol given intracerebroventricularly (i.c.v.). The ED50 values for clonidine, rilmenidine and ST-91 are 0.2, 0.01 and 16 nmol/rat i.c.v., respectively. The effect was reversed by the intracerebroventricularly injected α2B/2C-adrenoceptor antagonists prazosin and ARC-239, indicating the potential involvement of central α2B/2C-adrenoceptor subtype in the protective action. The gastroprotective effect of adrenoceptor stimulants was reversed by bilateral cervical vagotomy, suggesting that vagal nerve is likely to convey the central action to the periphery. In gastric mucosa both nitric oxide and prostaglandins may mediate the centrally-induced effect, since both indomethacin and NG-nitro-l-arginine reversed the protective effect of α2-adrenergic stimulants. Though expression of mRNA of α2B-, as well as α2A- and α2C-adrenoceptor subtypes was demonstrated in gastric mucosa of the rat, the hydrophilic ST-91, given peripherally (orally, subcutaneously), failed to exert mucosal protection, in contrast with clonidine and rilmenidine which were also effective. Consequently, while peripheral α2B-adrenoceptors are not likely to be involved in gastric mucosal protection, activation of central α2B-like adrenoceptor subtype may initiate a chain of events, which result in a vagal dependent gastroprotective action.

AB - The present study confirmed our previous assumption on the crucial role of central α2B-like adrenoceptor subtype in gastric mucosal defense. It was found that beside clonidine, rilmenidine, an α2/imidazoline receptor agonist and ST-91, an α2B-adrenoceptor preferring agonist inhibited the mucosal lesions induced by ethanol given intracerebroventricularly (i.c.v.). The ED50 values for clonidine, rilmenidine and ST-91 are 0.2, 0.01 and 16 nmol/rat i.c.v., respectively. The effect was reversed by the intracerebroventricularly injected α2B/2C-adrenoceptor antagonists prazosin and ARC-239, indicating the potential involvement of central α2B/2C-adrenoceptor subtype in the protective action. The gastroprotective effect of adrenoceptor stimulants was reversed by bilateral cervical vagotomy, suggesting that vagal nerve is likely to convey the central action to the periphery. In gastric mucosa both nitric oxide and prostaglandins may mediate the centrally-induced effect, since both indomethacin and NG-nitro-l-arginine reversed the protective effect of α2-adrenergic stimulants. Though expression of mRNA of α2B-, as well as α2A- and α2C-adrenoceptor subtypes was demonstrated in gastric mucosa of the rat, the hydrophilic ST-91, given peripherally (orally, subcutaneously), failed to exert mucosal protection, in contrast with clonidine and rilmenidine which were also effective. Consequently, while peripheral α2B-adrenoceptors are not likely to be involved in gastric mucosal protection, activation of central α2B-like adrenoceptor subtype may initiate a chain of events, which result in a vagal dependent gastroprotective action.

KW - Clonidine

KW - Expression of α-adrenoceptor subtypes

KW - Gastric mucosal damage

KW - Rat

KW - Rilmenidine

KW - ST-91

UR - http://www.scopus.com/inward/record.url?scp=34548473600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548473600&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2007.07.001

DO - 10.1016/j.neuint.2007.07.001

M3 - Article

C2 - 17707950

AN - SCOPUS:34548473600

VL - 51

SP - 289

EP - 296

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 5

ER -